Natixis Bio Rad Laboratories, Inc. Transaction History

Natixis

  • $17.6 Billion
  • Q3 2024

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
$268.26 - $339.48 $26,289 - $33,269
-98 Reduced 4.93%
1,888 $515,000
Q1 2024

May 13, 2024
BUY
$304.11 - $351.99 $19,767 - $22,879
65 Added 3.38%
1,986 $686,000
Q4 2023

Feb 13, 2024
BUY
$269.37 - $365.04 $145,459 - $197,121
540 Added 39.1%
1,921 $620,000
Q3 2023

Nov 14, 2023
BUY
$350.25 - $422.63 $34,324 - $41,417
98 Added 7.64%
1,381 $495,000
Q2 2023

Aug 11, 2023
BUY
$359.49 - $486.4 $211,020 - $285,516
587 Added 84.34%
1,283 $486,000
Q1 2023

May 12, 2023
SELL
$418.69 - $503.0 $125,188 - $150,397
-299 Reduced 30.05%
696 $333,000
Q4 2022

Feb 24, 2023
SELL
$351.71 - $456.01 $516,310 - $669,422
-1,468 Reduced 59.6%
995 $418,000
Q4 2022

Feb 13, 2023
BUY
$351.71 - $456.01 $368,592 - $477,898
1,048 Added 74.06%
2,463 $1.04 Million
Q3 2022

Nov 14, 2022
BUY
$412.59 - $563.26 $156,371 - $213,475
379 Added 36.58%
1,415 $591,000
Q2 2022

Aug 12, 2022
SELL
$463.67 - $597.16 $24.3 Million - $31.3 Million
-52,404 Reduced 98.06%
1,036 $513,000
Q1 2022

May 13, 2022
BUY
$524.57 - $735.42 $19.3 Million - $27.1 Million
36,886 Added 222.82%
53,440 $30.1 Million
Q4 2021

Feb 14, 2022
BUY
$708.84 - $794.68 $11.3 Million - $12.7 Million
15,981 Added 2789.01%
16,554 $12.5 Million
Q3 2021

Nov 12, 2021
BUY
$657.71 - $825.77 $46,039 - $57,803
70 Added 13.92%
573 $427,000
Q2 2021

Aug 13, 2021
SELL
$576.64 - $649.04 $83.2 Million - $93.6 Million
-144,225 Reduced 99.65%
503 $324,000
Q1 2021

May 14, 2021
BUY
$547.01 - $662.35 $50.5 Million - $61.2 Million
92,340 Added 176.26%
144,728 $82.7 Million
Q4 2020

Feb 12, 2021
BUY
$510.68 - $643.45 $26.8 Million - $33.7 Million
52,388 New
52,388 $30.5 Million
Q3 2020

Nov 12, 2020
SELL
$454.43 - $535.6 $308,557 - $363,672
-679 Closed
0 $0
Q2 2020

Aug 13, 2020
SELL
$334.87 - $493.06 $7.21 Million - $10.6 Million
-21,517 Reduced 96.94%
679 $307,000
Q1 2020

May 14, 2020
BUY
$320.01 - $409.07 $1.98 Million - $2.53 Million
6,177 Added 38.56%
22,196 $7.78 Million
Q4 2019

Feb 14, 2020
SELL
$319.73 - $374.2 $7.15 Million - $8.36 Million
-22,354 Reduced 58.25%
16,019 $5.92 Million
Q3 2019

Nov 13, 2019
BUY
$304.55 - $345.24 $11.7 Million - $13.2 Million
38,373 New
38,373 $12.8 Million
Q2 2019

Aug 13, 2019
SELL
$286.93 - $312.59 $26.9 Million - $29.3 Million
-93,823 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$224.3 - $317.41 $21 Million - $29.8 Million
93,823 New
93,823 $28.5 Million
Q3 2018

Nov 14, 2018
SELL
$289.28 - $326.15 $1.96 Million - $2.21 Million
-6,774 Closed
0 $0
Q2 2018

Aug 14, 2018
SELL
$244.1 - $303.88 $1.27 Million - $1.59 Million
-5,221 Reduced 43.53%
6,774 $1.96 Million
Q1 2018

May 15, 2018
BUY
$233.97 - $274.11 $1.02 Million - $1.19 Million
4,357 Added 57.04%
11,995 $3 Million
Q4 2017

Feb 14, 2018
BUY
$216.94 - $271.3 $270,958 - $338,853
1,249 Added 19.55%
7,638 $1.82 Million
Q3 2017

Nov 14, 2017
BUY
$212.27 - $242.28 $1.36 Million - $1.55 Million
6,389
6,389 $1.42 Million

Others Institutions Holding BIO

# of Institutions
457
Shares Held
18.2M
Call Options Held
19.5K
Put Options Held
13.9K
View Full List

About BIO-RAD LABORATORIES, INC.

BIO Quotes by TradingView
  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.37B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Natixis Portfolio

Follow Natixis and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

News

Stay updated on Natixis with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email